Glow-in-the-dark dye helps surgeons spot hidden pancreatic cancer
NCT ID NCT03384238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a dye called panitumumab-IRDye800 that attaches to pancreatic cancer cells and makes them glow under a special camera during surgery. The goal is to help surgeons see and remove all cancer tissue, including tiny spots that might otherwise be missed. About 27 adults with pancreatic cancer who are scheduled for surgery will take part. The study checks for side effects and how well the dye works at finding cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University, School of Medicine
RECRUITINGPalo Alto, California, 94304, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill rouse the immune system against pancreatic cancer?
- A sound wave that could expose hidden pancreatic cancer?
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
- Light-Activated therapy targets pancreatic tumors during surgery
- Engineered immune cells take aim at Mesothelin-Positive tumors